NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I agree on the potential pricing. I was hesitant to suggest high prices, as I had been worried about construction constraints. But once I started thinking through the Flaskworks scaling and consistency potential with automation, plus just the number of patients with a broad array of brain tumors and other solid tumor patients who might use it off-label, I think the potential to reach a large share price, assuming TLD that are as exciting as many of us anticipate and assuming the likelihood of approval.

I think you start putting the numbers together, and then even just a reasonable multiple gets you to a very nice potential share price despite the number of shares expected to be outstanding once options are all exercised. If they are able to get the kind of revenues the scaling and potential demand suggest are possible, even share buybacks would be easy if the share price lingers, I think. The potential revenues, if approval happens and results match expectations, open up many possibilities.